We recommend that functional validation and exploring variant-variant interactions within relevant genes such as UCP3 and PCSK1 will be critical to improving our understanding of monogenic (rare) obesity and refining personalized treatment strategies. This evidence concerns the gene UCP3 and obesity disorder.